CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
research
Prediction of short- and medium-term efficacy of biosimilar infliximab therapy. Do trough levels/antidrug antibody levels or clinical/biochemical markers play a more important role?
Authors
László Bene
Renáta Bor
+23 more
Edina Bíró
Klaudia Farkas
Beáta Gasztonyi
Krisztina B. Gecse
Petra Anna Golovics
Lóránt Gönczi
Tünde Kristóf
Zsuzsanna Kürti
László Lakatos
Péter László Lakatos
Barbara Dorottya Lovász
Pál Miheller
Tamás Molnár
Károly Palatka
Mária Papp
Árpád Patai
Mariann Rutka
Ágnes Salamon
Tamás Szamosi
Zoltán Szepes
Gábor Tamás Tóth
Áron Vincze
Zsuzsanna Végh
Publication date
22 January 2018
Publisher
Abstract
K
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
University of Debrecen Electronic Archive
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:dea.lib.unideb.hu:2437/231...
Last time updated on 12/09/2018